History
A list of downloadable documents created during development.
Review proposal consultation
Background information
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): final appraisal determination
-
-
-
-
Consultee and commentator comments on the ACD
-
-
-
-
-
The Psoriasis and Psoriatic Arthritis Alliance response to PsA ACD (PDF 72 KB)
-
-
-
NHS Quality Improvement Scotland response to PsA ACD (PDF 19 KB)
-
-
-
Expert comments on the ACD
-
-
-
-
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): appraisal consultation document
-
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): appraisal consultation document
-
-
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: evaluation report
-
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: overview (PDF 257 KB)
-
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: assessment report
-
-
-
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: appendix 10.13 (PDF 46 KB)
-
-
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: consultee and commentator comments on the assessment report
-
-
-
-
-
-
-
-
-
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: non-manufacturer submission
-
-
-
-
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: manufacturer submissions
-
-
-
-
Psoriatic arthritis - etanercept, infliximab, & adalimumab (review) ACD: expert written personal statements
-
-
-